For preoperative NT-proBNP ≥100 pg ml −1, 13/45 (28.9%) patients who stopped RAS inhibitors had postoperative infection, compared with 16/56 (28.6%) who continued RAS inhibitors (OR for stopping 1.02; 95% CI 0.43–2.42). Here, NPPB is linked to infection.